MedPath

Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.

Conditions
The Gold Standard for Current SARS CoV2 Detection is RT-PCR
Registration Number
NCT04339686
Lead Sponsor
Poitiers University Hospital
Brief Summary

All patients included in this search will be on anonymized file: Symptomatic patients consulting for suspicion of COVID 19 with indication to a screening (RT-PCR, Scanner) according to the criteria of the Ministry of Health.

To evaluate the diagnostic performance of chest CT in screening for COVID-related lung injury in patients with a clinical suspicion of COVID.

CT scan results for COVID according to French thoracic imaging society will be dichotomized into evocative or compatible (considered positive) non-evocative (considered negative) The results will be compared to the gold standard corresponding to a multiparametric element: the discharge summary.

Ct Scan performance will be recorded and analyzed.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
56000
Inclusion Criteria
  • All patients suspected of COVID 19 consulting for diagnostic
Exclusion Criteria
  • Delay between RT-PCR and Thoracic Scan greater than 6 days.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic performance of chest CT in screening for pulmonary lesions in clinical suspicions of COVID.1 month

CT Report will dichotomized into evocative or non-evocative for COVID-related lung injury.

Secondary Outcome Measures
NameTimeMethod
Compare the diagnostic performance of chest CT and RT-PCR in COVID 19 at the initial consultation (screening).1 month

Initial virological RT-PCR results: positive or negative depending on the laboratories of the institutions.

Scanner results according to French Thoracic Imaging Society.

Trial Locations

Locations (1)

Chu de Poitiers

🇫🇷

Poitiers, France

Chu de Poitiers
🇫🇷Poitiers, France
Guillaume HERPE
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.